← Back to Conditions

Pyrroline-5-carboxylate reductase 2 related microcephaly, progressive leucoencephalopathy

disorder
SNOMED 1237421000CUI C4225332

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Mental and motor retardation
Always present (100%)HP:0001263
Postnatal microcephaly
Always present (100%)HP:0005484
Reduced cerebral white matter volume
Always present (100%)HP:0034295
Feeding difficulties
Very frequent (80-99%)HP:0011968
Global developmental delay, severe
Very frequent (80-99%)HP:0011344
Inability to walk
Very frequent (80-99%)HP:0002540
Mental deficiency
Very frequent (80-99%)HP:0001249
Microcephaly, progressive
Very frequent (80-99%)HP:0000253
Nonverbal
Very frequent (80-99%)HP:0001344
Poor weight gain
Very frequent (80-99%)HP:0001508
Bulbous nasal tip
Frequent (30-79%)HP:0000414
Central hypotonia
Frequent (30-79%)HP:0001252
CNS hypomyelination
Frequent (30-79%)HP:0003429
Epilepsy
Frequent (30-79%)HP:0001250
Hyperintensity of cerebral white matter on MRI
Frequent (30-79%)HP:0030890
Hypoplasia of corpus callosum
Frequent (30-79%)HP:0002079
Involuntary muscle stiffness, contraction, or spasm
Frequent (30-79%)HP:0001257
Malformation of face
Frequent (30-79%)HP:0001999
Mental deterioration in childhood
Frequent (30-79%)HP:0002376
Muscle wasting
Frequent (30-79%)HP:0003202
Prominent eyelashes
Frequent (30-79%)HP:0011231
Protruding ear
Frequent (30-79%)HP:0000411
Severe demyelination of the white matter
Frequent (30-79%)HP:0007258
Small upper jaw
Frequent (30-79%)HP:0000327
Vomiting
Frequent (30-79%)HP:0002013
Absence of corpus callosum
Occasional (5-29%)HP:0001274
Aggression
Occasional (5-29%)HP:0000718
Appendicular hypertonia
Occasional (5-29%)HP:0002509
Arachnodactyly
Occasional (5-29%)HP:0001166
Ataxia
Occasional (5-29%)HP:0001251

Quick Facts

SNOMED CT
1237421000
UMLS CUI
C4225332
Fully Specified Name
Pyrroline-5-carboxylate reductase 2 related microcephaly, progressive leukoencephalopathy (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
30
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.